Empallo provides convenient, virtual cardiac care focused on conditions like heart failure, arrhythmias, and hypertension. Specialists deliver personalized treatment plans through telehealth visits, including medication management and lifestyle guidance. The service coordinates necessary in-person testing and referrals while prioritizing patient privacy and accessibility.
Funding
$30K raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Heart failure management often lacks efficient data utilization, hindering the translation of insights into timely and effective health interventions. This can lead to suboptimal patient outcomes and limited accessibility to quality cardiovascular care, especially in value-based care models.
Solution
Empallo leverages AI-driven analytics to improve value-based care for heart failure patients by transforming data insights into actionable strategies. The company's platform aims to enhance patient experience, improve health outcomes, and increase accessibility to cardiovascular care. By discovering new insights from data, Empallo seeks to enable more effective and proactive management of heart failure, ultimately saving hearts and improving the quality of life for patients.
Target Audience
The primary target audience includes healthcare providers and organizations involved in value-based care models for heart failure management, as well as patients seeking improved access to quality cardiovascular care.
Features
- AI-powered analytics for cardiovascular data
- Data-driven insights for actionable health interventions
- Focus on improving patient outcomes in heart failure management
- Emphasis on enhancing accessibility to cardiovascular care